Seqens Seqens

X

CAS 88150-62-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 88150-62-3
Also known as: Phthaloyl amlodipine, 88150-62-3, Phthaloylamlodipine, (+/-)-phthalimidoamlodipine, 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate, 9qao5crp93
Molecular Formula
C28H27ClN2O7
Molecular Weight
539.0  g/mol
InChI Key
AHHPZGUFLGCZCF-UHFFFAOYSA-N
FDA UNII
9QAO5CRP93

1 2D Structure

CAS 88150-62-3

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-O-ethyl 5-O-methyl 4-(2-chlorophenyl)-2-[2-(1,3-dioxoisoindol-2-yl)ethoxymethyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
2.1.2 InChI
InChI=1S/C28H27ClN2O7/c1-4-38-28(35)24-21(15-37-14-13-31-25(32)17-9-5-6-10-18(17)26(31)33)30-16(2)22(27(34)36-3)23(24)19-11-7-8-12-20(19)29/h5-12,23,30H,4,13-15H2,1-3H3
2.1.3 InChI Key
AHHPZGUFLGCZCF-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN3C(=O)C4=CC=CC=C4C3=O
2.2 Other Identifiers
2.2.1 UNII
9QAO5CRP93
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Phthaloyl Amlodipine

2. 88150-62-3

3. Phthaloylamlodipine

4. (+/-)-phthalimidoamlodipine

5. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

6. 9qao5crp93

7. Amlodipine Related Compound D

8. Mfcd07782096

9. 3,5-pyridinedicarboxylic Acid, 4-(2-chlorophenyl)-2-((2-(1,3-dihydro-1,3-dioxo-2h-isoindol-2-yl)ethoxy)methyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester

10. 3-o-ethyl 5-o-methyl 4-(2-chlorophenyl)-2-[2-(1,3-dioxoisoindol-2-yl)ethoxymethyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

11. 3-ethyl 5-methyl (4rs)-4-(2-chlorophenyl)-2-((2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

12. 4-(2-chloroethyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-((2-phthalimidoethoxy)methyl)-1,4-dihydropyridine

13. 4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-2-((2-phthalimidoethoxy)methyl)-1,4-dihydropyridine

14. 3-ethyl 5-methyl (4rs)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

15. Amlodipine Ep Impurity A

16. Unii-9qao5crp93

17. Amlodipine Besilate Impurity A

18. Chembl295696

19. Schembl3185862

20. Dtxsid30893841

21. Bcp13465

22. Amlodipine Besilate Impurity A [ep]

23. Akos015895609

24. Sb64137

25. 3,5-pyridinedicarboxylic Acid,4-(2-chlorophenyl)-2-[[2-(1,3-dihydro-1,3-dioxo-2h-isoindol-2-yl)ethoxy]methyl]-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester

26. Ac-19466

27. As-75270

28. Sy107510

29. Cs-0136897

30. Ft-0658434

31. P2406

32. Amlodipine Related Compound D [usp-rs]

33. Ec 413-410-3

34. F19238

35. 150p623

36. A842484

37. Amlodipine Besilate Impurity A [ep Impurity]

38. Q-201577

39. Q27272892

40. 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-(2-(1,3-dihydro-1,3-dioxo-(2h)isoindol-2-yl)-ethoxymethyl)-6-methyl-3,5-pyridinedicarboxylate

41. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1,3-dioxo-2,3-dihydro-1h-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

42. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1.3-dioxo-1.3-dihydro-2h-isoindol-2-yl) Ethoxy] Methyl}-6-methyl-1.4-dihydro-3.5-pyridine Dicarboxylate

43. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1.3-dioxo-1.3-dihydro-2h-isoindol-2-yl) Ethoxy]methyl}-6-methyl-1.4-dihydro-3.5-pyridine Dicarboxylate

44. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1.3-dioxo-1.3-dihydro-2h-isoindol-2-yl)ethoxy]methyl}-6-methyl-1.4-dihydro-3.5-pyridine Dicarboxylate

45. 3-ethyl-5-methyl-4-(2-chlorophenyl)-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

46. 4-(2-chlorophenyl)-2-methyl-6-[(2-phthalimidylethoxy)methyl]-1,4-dihydropyridine-3,5-dicarboxylic Acid 3-methyl 5-ethyl Ester

47. 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-(2-phthalimidoethoxy)methyl-1,4-dihydropyridine

48. 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[2-phthalimidoethoxymethyl]-1,4-dihydropyridine

49. Phthaloyl Amlodipine; Amlodipine Usp Rc D; Phthalimido Amlodipine; 3-ethyl 5-methyl (4rs)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 539.0 g/mol
Molecular Formula C28H27ClN2O7
XLogP34.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count11
Exact Mass538.1506789 g/mol
Monoisotopic Mass538.1506789 g/mol
Topological Polar Surface Area111 Ų
Heavy Atom Count38
Formal Charge0
Complexity999
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag Spain
Digital Content Digital Content
88150-62-3
Amlodipine
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, ...
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and bus...
DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
Flag India
Digital Content Digital Content
88150-62-3
Amlodipine
Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs...
Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth therapeutic areas, with an emphasis on affordability, quality and timely delivery. It also provides end-to-end CDMO services. Headquartered in Hyderabad, Tagoor Labs is a fast-growing Indian pharma company that serves both branded and generic companies worldwide. The company’s organizational function includes R&D, supply chain, manufacturing, quality testing, quality assurance, regulatory affairs, marketing & sales, and packaging & warehousing departments.
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in deliveri...
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals. At Aurore, we aim to push the boundaries to manufacture and deliver high quality products that can be relied upon by both customers and regulators. Our thrust on rapidly adding capabilities have led us to acquire, integrate and expand our reach across the geographies.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over ...
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past six decades, we have been developing and manufacturing affordable medicines for patients around the world. Our innovation-led drug discovery processes ensure the health and well-being of people around the world. Our enhanced investment in innovation and a strong track record in research and development have produced medical miracles that have changed lives and made a profound impact on real life.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over ...
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past six decades, we have been developing and manufacturing affordable medicines for patients around the world. Our innovation-led drug discovery processes ensure the health and well-being of people around the world. Our enhanced investment in innovation and a strong track record in research and development have produced medical miracles that have changed lives and made a profound impact on real life.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Mesylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine
Dorrapharma is engaged in R&D, manufacture and market of intermediate, API (Active Pharmaceutical Ingredi...
Dorrapharma is engaged in R&D, manufacture and market of intermediate, API (Active Pharmaceutical Ingredients) and formulation. We stick to raise the value both for the company and customer, and strive for serving for the society and caring of the others. We devote ourselves completely to the technology innovation and brand build, and make every effort to foster the core competence for the company. We are in a progress of becoming a global leading pharmaceutical server.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine
Smruthi Organics Limited was started as an API and Intermediates manufacturing company in 1989 by Chairm...
Smruthi Organics Limited was started as an API and Intermediates manufacturing company in 1989 by Chairman and Managing Director, Mr. Purushotham Eaga. The company is a public limited company and is listed on the Bombay Stock Exchange. We manufacture API products in the anti - diabetic, anti - hypertension and anti - infectives therapeutic categories. We cater to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas and Africa. Our client list of large domestic and international pharma companies is testimony to our high quality and reliable service.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY